Loading cancer entity…
Loading cancer entity…
Clinical trials
6,746 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,045)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01934465 | Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment | completed | — | 300 | Hellenic Oncology Research GroupOTHER | 1 | Oct 24, 2014 | clinicaltrials |
| NCT01844791 | An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients | completed | Phase 2 | 25 | Oncozyme Pharma Inc.INDUSTRY | 1 | Oct 21, 2014 |
| NCT02014324 | Single Scope Staging of Lung Cancer With Endosonography(SCORE) | completed | — | 215 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 2 | Oct 20, 2014 | clinicaltrials |
| NCT00088959 | Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Oct 10, 2014 | clinicaltrials |
| NCT01799382 | Role of Rapid On-site Evaluation for Mutational Analysis of EBUS-TBNA Specimens | completed | N/A | 126 | Maggiore Bellaria Hospital, BolognaOTHER | 1 | Oct 7, 2014 | clinicaltrials |
| NCT00201825 | A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients | completed | Phase 2 | 29 | Tony Bekaii-SaabOTHER | 1 | Oct 6, 2014 | clinicaltrials |
| NCT01473563 | A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 52 | Eli Lilly and CompanyINDUSTRY | 2 | Oct 6, 2014 | clinicaltrials |
| NCT00245063 | AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer | completed | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Oct 2, 2014 | clinicaltrials |
| NCT01206894 | Pre-Operative Assessment of Chest Wall Invasion in NSCLC Using Pre-Operative, Surgeon Performed Ultrasound(CT0010) | completed | N/A | 25 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Sep 29, 2014 | clinicaltrials |
| NCT00986674 | Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 140 | National Cancer Institute (NCI)NIH | 1 | Sep 26, 2014 | clinicaltrials |
| NCT00700180 | A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer. | completed | Phase 2 | 303 | Hoffmann-La RocheINDUSTRY | 16 | Sep 25, 2014 | clinicaltrials |
| NCT00874419 | Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation(ML20981) | completed | Phase 3 | 165 | Tongji UniversityOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT01459185 | A Feasibility Study of Oral Adjuvant Chemotherapy With S-1 | completed | Phase 2 | 55 | Tomoshi TsuchiyaOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT01031225 | A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 113 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Sep 19, 2014 | clinicaltrials |
| NCT00056537 | ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer | completed | Phase 1 | 44 | Active Biotech ABINDUSTRY | 3 | Aug 27, 2014 | clinicaltrials |
| NCT00132379 | ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 1 | 13 | Active Biotech ABINDUSTRY | 3 | Aug 27, 2014 | clinicaltrials |
| NCT01729689 | Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers | completed | N/A | 13 | Stanford UniversityOTHER | 1 | Aug 22, 2014 | clinicaltrials |
| NCT00118144 | Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Aug 21, 2014 | clinicaltrials |
| NCT00372788 | AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen | completed | Phase 2 | 88 | AstraZenecaINDUSTRY | 3 | Aug 13, 2014 | clinicaltrials |
| NCT02211833 | Dose Escalation Study of BI 2536 With Pemetrexed in Previously Treated Patients With Non-small-cell Lung Cancer | completed | Phase 1 | 41 | Boehringer IngelheimINDUSTRY | 0 | Aug 8, 2014 | clinicaltrials |
| NCT00321334 | Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC | completed | Phase 3 | 410 | Chinese Society of Lung CancerOTHER | 1 | Aug 6, 2014 | clinicaltrials |
| NCT01236716 | Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung(C-TONG1002) | completed | Phase 2 | 126 | Chinese Society of Lung CancerOTHER | 1 | Aug 6, 2014 | clinicaltrials |
| NCT00193921 | Chemoradiotherapy in Patients With Localised Lung Cancer | completed | Phase 2 | 82 | Trans Tasman Radiation Oncology GroupOTHER | 1 | Aug 4, 2014 | clinicaltrials |
| NCT00351598 | Lung Tumour Volume Database | completed | — | 531 | Trans Tasman Radiation Oncology GroupOTHER | 3 | Aug 4, 2014 | clinicaltrials |
| NCT01668823 | Photodynamic Therapy in Treating Patients With Lung Cancer | completed | Phase 1 | 17 | Roswell Park Cancer InstituteOTHER | 1 | Jul 31, 2014 | clinicaltrials |
| NCT02204059 | Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Non-small Cell Lung Cancer | completed | Phase 1 | 9 | Boehringer IngelheimINDUSTRY | 0 | Jul 30, 2014 | clinicaltrials |
| NCT00796549 | BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) Patients | completed | Phase 2 | 70 | Boehringer IngelheimINDUSTRY | 1 | Jul 22, 2014 | clinicaltrials |
| NCT01165216 | Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer | completed | Phase 1 | 15 | Bristol-Myers SquibbINDUSTRY | 1 | Jul 22, 2014 | clinicaltrials |
| NCT02182102 | Dose Escalation of BIBF 1120 Combined With Pemetrexed in Advanced Non Small Cell Lung Cancer | completed | Phase 1 | 26 | Boehringer IngelheimINDUSTRY | 0 | Jul 18, 2014 | clinicaltrials |
| NCT02182232 | A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer | completed | Phase 1 | 33 | Boehringer IngelheimINDUSTRY | 0 | Jul 18, 2014 | clinicaltrials |
| NCT00325494 | A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer | completed | Phase 1 | 24 | MorphotekINDUSTRY | 1 | Jul 17, 2014 | clinicaltrials |
| NCT00415818 | Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 148 | TransgeneINDUSTRY | 4 | Jul 16, 2014 | clinicaltrials |
| NCT01362296 | An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer | completed | Phase 2 | 134 | GlaxoSmithKlineINDUSTRY | 8 | Jul 11, 2014 | clinicaltrials |
| NCT00661778 | A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 50 | Hoffmann-La RocheINDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT01240447 | Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients | completed | Phase 2 | 7 | Laboratorio Elea Phoenix S.A.INDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT01996332 | A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 1,805 | Hoffmann-La RocheINDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT00499109 | Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC | completed | Phase 3 | 275 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 3 | Jul 9, 2014 | clinicaltrials |
| NCT00148798 | Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)(FLEX) | completed | Phase 3 | 1,861 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 28 | Jun 25, 2014 | clinicaltrials |
| NCT00620971 | Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC | completed | Phase 2 | 77 | Hellenic Oncology Research GroupOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT00879866 | EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 15 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Jun 23, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00368927 | Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia | completed | Phase 2 | 61 | National Cancer Institute (NCI)NIH | 2 | May 23, 2014 | clinicaltrials |
| NCT00778167 | Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT01004250 | A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer | completed | Phase 2 | 109 | Eli Lilly and CompanyINDUSTRY | 5 | May 21, 2014 | clinicaltrials |
| NCT00003869 | Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer | completed | Phase 3 | 186 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT01362400 | A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 226 | Infinity Pharmaceuticals, Inc.INDUSTRY | 6 | May 19, 2014 | clinicaltrials |
| NCT00820755 | Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)(NEXT) | completed | Phase 3 | 583 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | May 5, 2014 | clinicaltrials |
| NCT00406302 | Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC) | completed | Phase 2 | 41 | Wolfgang HilbeOTHER | 1 | Apr 29, 2014 | clinicaltrials |
| NCT01525199 | Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.(IDENTIFY) | completed | — | 450 | AstraZenecaINDUSTRY | 1 | Apr 14, 2014 | clinicaltrials |
| NCT01936571 | Usefulness of Blood Biomarkers for Overall Survival in NSCLC | completed | — | 250 | Maastricht Radiation OncologyOTHER | 1 | Apr 11, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Oct 24, 2014source: clinicaltrials